Equity
Equity Analysis
Price
 Gainers & Losers
 Weekly Gainers & Losers
 Monthly Gainers & Losers
 Out & Under Performers
 Advances & Declines
 New Highs & Lows
 52 Week Highs & Lows
 Weightage
 Only Buyers & Sellers
 Historical Returns
Volume
Analysis
Exchange Holidays
News Analysis
Corporate Action
Corporate Info
Other Market
  HOME  > Equity HOME  > Equity Analysis  > Analysis > Rising VDP
BSE   Rising VDP    
 Switch to NSE   
13-Apr-2026 15:59
Company Name
 
09-Apr-2026  
Traded Qty  Del.Volume  Price 
10-Apr-2026  
Traded Qty  Del.Volume  Price 
13-Apr-2026  
Traded Qty  Del.Volume  Price 
Rise in price
%
 Astrazeneca Pharma I
7817 4317 8051.00
20230 5181 8299.00
55429 10274 8725.00
8.37
 ASTRAZEN-N1
7817 4317 8051.00
20230 5181 8299.00
55429 10274 8725.00
8.37
 Insolation Energy
1615354 521435 106.96
4164794 1229370 119.04
9906675 1798733 131.40
22.85
 Indoco Remedies
22330 11760 201.42
37333 18493 202.41
52995 30242 211.60
5.05
 Secmark Consultancy
2124 1600 110.40
22763 9940 130.82
75943 18577 134.43
21.77
 Unimech Aerospace
176028 67911 778.80
192508 92493 856.65
443995 137344 907.35
16.51
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.